For example, patients who started taking a GLP-1 RA were found to have a significantly higher CCI score (1.53 vs. 1.36; P < 0.001), and they were more likely to be diagnosed with comorbid depression (11.47 vs. 8.36%; P < 0.001). This evidence concerns the gene GCG and major depressive disorder.